Ticker archive · $TVTX

$TVTX Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $TVTX — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$TVTX – Travere Reports Q3 Net Loss of $52.3M Despite 120% Surge in FILSPARI Sales

Travere Therapeutics, Inc.
· SEC_8K · All $TVTX
?? Negative AI Sentiment (-2.0 / 10)
  • FILSPARI U.S. net sales reached $200.2M (+120% YoY), driving net product sales to $220.2M.
  • GAAP net loss widened to -$52.3M (-$0.55 per share) compared to net income of $25.7M ($0.29 per share) in Q3 2025.
  • Cash and cash equivalents stood at $123.5M as of September 30, 2026.